دورية أكاديمية

The effect of myeloablative radiation on urinary bladder mast cells.

التفاصيل البيبلوغرافية
العنوان: The effect of myeloablative radiation on urinary bladder mast cells.
المؤلفون: Smith J; Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, 4226, Australia., Tan JKH; Clem Jones Centre for Regenerative Medicine, Bond University, Gold Coast, QLD, 4226, Australia., Short C; Clem Jones Centre for Regenerative Medicine, Bond University, Gold Coast, QLD, 4226, Australia., O'Neill H; Clem Jones Centre for Regenerative Medicine, Bond University, Gold Coast, QLD, 4226, Australia., Moro C; Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, 4226, Australia. cmoro@bond.edu.au.
المصدر: Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6219. Date of Electronic Publication: 2024 Mar 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Urinary Bladder* , Cystitis*/etiology, Mice ; Animals ; Mast Cells/physiology ; Mice, Inbred C57BL ; Pelvis
مستخلص: Radiation-induced cystitis is an inflammatory condition affecting the urinary bladder, which can develop as a side effect of abdominopelvic radiotherapy, specifically external-beam radiation therapy or myeloablative radiotherapy. A possible involvement of mast cells in the pathophysiology of radiation-induced cystitis has been indicated in cases of external-beam radiation therapy; however, there is no evidence that these findings apply to the myeloablative aetiology. As such, this study investigated potential changes to urinary bladder mast cell prevalence when exposed to myeloablative radiation. Lethally irradiated C57BL/6J mice that received donor rescue bone marrow cells exhibited an increased mast cell frequency amongst host leukocytes 1 week following irradiation. By 4 weeks, no significant difference in either frequency or cell density was observed. However mast cell diameter was smaller, and a significant increase in mast cell number in the adventitia was observed. This study highlights that mast cells constitute a significant portion of the remaining host leukocyte population following radiation exposure, with changes to mast cell distribution and decreased cell diameter four weeks following radiation-induced injury.
(© 2024. The Author(s).)
References: Am J Pathol. 2011 Feb;178(2):640-51. (PMID: 21281796)
Cent European J Urol. 2012;65(4):200-3. (PMID: 24578962)
Sci Rep. 2017 Jun 14;7(1):3495. (PMID: 28615666)
Histochem Cell Biol. 2019 Oct;152(4):253-269. (PMID: 31392409)
PLoS One. 2020 Oct 29;15(10):e0241388. (PMID: 33119677)
Haematologica. 2010 Jul;95(7):1183-90. (PMID: 20410183)
J Cell Biol. 1977 Sep;74(3):690-7. (PMID: 71300)
Immunity. 2016 Dec 20;45(6):1258-1269. (PMID: 27939674)
Int Immunopharmacol. 2020 Jun;83:106334. (PMID: 32179244)
Biology (Basel). 2022 Jun 28;11(7):. (PMID: 36101361)
Adv Radiat Oncol. 2016 Oct-Dec;1(4):333-343. (PMID: 28217761)
Am J Physiol Cell Physiol. 2019 Sep 1;317(3):C544-C555. (PMID: 31241987)
Cell Prolif. 2018 Oct;51(5):e12475. (PMID: 30062695)
J Pathol. 2022 Feb;256(2):223-234. (PMID: 34731491)
Bone Marrow Transplant. 2015 Nov;50(11):1432-7. (PMID: 26168069)
J Cell Mol Med. 2022 Mar;26(5):1621-1628. (PMID: 35088536)
Urology. 2012 Jul;80(1):225.e13-8. (PMID: 22521193)
J Radiat Res. 2020 Nov 16;61(6):969-976. (PMID: 32888029)
Urol Int. 2004;72(4):299-302. (PMID: 15153726)
Am J Blood Res. 2020 Oct 15;10(5):217-230. (PMID: 33224566)
Nat Rev Urol. 2010 Apr;7(4):206-14. (PMID: 20212517)
Clin Exp Pharmacol Physiol. 2016 Jul;43(7):698-705. (PMID: 27117224)
J Urol. 2015 Jun;193(6):1994-2000. (PMID: 25596361)
PLoS One. 2016 Jun 23;11(6):e0158104. (PMID: 27337047)
Radiat Res. 2016 Feb;185(2):182-9. (PMID: 26771172)
Adv Urol. 2015;2015:346812. (PMID: 26798335)
Sci Immunol. 2023 Mar 17;8(81):eadc9417. (PMID: 36930731)
Am J Physiol Renal Physiol. 2002 Dec;283(6):F1304-12. (PMID: 12426235)
PLoS Biol. 2010 Jun 29;8(6):e1000412. (PMID: 20613859)
Front Physiol. 2020 Jun 23;11:705. (PMID: 32714206)
Int J Nephrol. 2012;2012:681473. (PMID: 22506110)
Support Care Cancer. 2022 Jun;30(6):4953-4959. (PMID: 35179653)
Best Pract Res Clin Haematol. 2007 Jun;20(2):329-48. (PMID: 17448965)
Rev Urol. 2016;18(2):57-65. (PMID: 27601964)
In Vivo. 2022 May-Jun;36(3):1203-1221. (PMID: 35478105)
Ther Adv Infect Dis. 2021 Feb 3;8:2049936121991377. (PMID: 33614030)
Blood. 2002 Sep 1;100(5):1611-8. (PMID: 12176879)
Mucosal Immunol. 2022 Jun;15(6):1127-1142. (PMID: 36180582)
J Urol. 2015 Aug;194(2):578-84. (PMID: 25839382)
Neurourol Urodyn. 2014 Jan;33(1):9-16. (PMID: 23847015)
STAR Protoc. 2022 Dec 16;3(4):101755. (PMID: 36223269)
Micron. 2013 Apr;47:18-23. (PMID: 23465886)
Mol Immunol. 2015 Jan;63(1):9-17. (PMID: 24598075)
Urology. 2016 Feb;88:14-21. (PMID: 26571081)
Br J Pharmacol. 1998 Dec;125(7):1491-500. (PMID: 9884078)
Int Urol Nephrol. 2023 Dec;55(12):3005-3014. (PMID: 37620625)
PLoS Pathog. 2015 Jul 16;11(7):e1005044. (PMID: 26182347)
Indian J Urol. 2011 Apr;27(2):272-3. (PMID: 21814321)
Int J Mol Sci. 2022 Feb 06;23(3):. (PMID: 35163758)
J Dermatol Sci. 2008 Jan;49(1):7-19. (PMID: 18024086)
Cancer Biother Radiopharm. 2012 Mar;27(2):119-23. (PMID: 22149642)
Am J Transl Res. 2018 Mar 15;10(3):1036-1052. (PMID: 29636892)
Acta Pathol Jpn. 1990 Feb;40(2):107-15. (PMID: 2140233)
N Engl J Med. 2004 Nov 25;351(22):2276-85. (PMID: 15564544)
Int Urol Nephrol. 2010 Sep;42(3):629-35. (PMID: 19784793)
Nat Rev Immunol. 2015 Oct;15(10):655-63. (PMID: 26388331)
Front Immunol. 2019 Oct 18;10:2470. (PMID: 31681336)
Biomed Res Int. 2015;2015:967680. (PMID: 26351640)
تواريخ الأحداث: Date Created: 20240315 Date Completed: 20240318 Latest Revision: 20240318
رمز التحديث: 20240318
مُعرف محوري في PubMed: PMC10940702
DOI: 10.1038/s41598-024-56655-5
PMID: 38485999
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-024-56655-5